Medicare Enrolled

Dr. Patrick Frey, MD

Urology Physician · Grapevine, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1625 LANCASTER DR, Grapevine, TX 76051
2149158502
Registered in NPPES since 2005
NPI: 1932195328 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Frey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Frey? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Frey

Dr. Patrick Frey is an urology physician in Grapevine, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Frey performed 3,349 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Frey received a total of $2,917 from 42 pharmaceutical and/or device companies across 139 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Frey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 36% volume in TX $2,917 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
3,349
Medicare services
Top 36% in TX for urology physician
Not available
Unique patients (not deduplicated)
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
640 $64 $183
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
472 $8 $16
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
354 $88 $259
PSA test (prostate cancer screening) 315 $18 $37
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
274 $2 $5
Urine culture, bacterial identification
A laboratory test that grows and identifies bacteria from a urine sample to detect infections.
132 $8 $16
Urine culture, bacterial colony count
A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections.
113 $8 $16
Leuprolide acetate (for depot suspension), 7.5 mg 100 $133 $378
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
98 $187 $494
Total testosterone level test
A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women.
92 $25 $52
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
87 $121 $336
Bacterial culture, aerobic
A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms.
78 $8 $16
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
78 $76 $226
Antibiotic sensitivity test
A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods.
76 $8 $17
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
66 $10 $21
Injection of biodegradable material next to prostate
A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland.
45 $2,293 $6,009
Hormone pellet insertion under the skin
A small hormone pellet is placed just beneath the skin to release medication slowly over time.
44 $76 $191
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
40 $1,260 $2,992
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
37 $188 $491
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
37 $106 $282
Injection, garamycin, gentamicin, up to 80 mg 29 $2 $6
Free PSA test
A blood test that measures the amount of unbound prostate-specific antigen in the blood.
28 $18 $37
Total estradiol level test
A blood test that measures the total amount of estradiol, a form of estrogen, in the body.
24 $27 $56
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
23 $104 $262
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
22 $8 $22
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
21 $27 $70
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
13 $61 $156
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
11 $326 $816
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.3% high complexity
5.7% medium
94.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,917
Total received (2018-2024)
Avg $417/year across 7 years
Bottom 48% in TX for urology physician
42
Companies
139
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$587
2023
$559
2022
$469
2021
$305
2020
$184
2019
$718
2018
$94

Payments by company (2024)

Sumitomo Pharma America, Inc.
$85
Ferring Pharmaceuticals Inc.
$76
Boston Scientific Corporation
$66
PFIZER INC.
$58
Innovation Technologies Inc
$47
PROCEPT BioRobotics Corporation
$42
Dendreon Pharmaceuticals LLC
$31
ABBVIE INC.
$26
Tempus AI, Inc
$25
Astellas Pharma US Inc
$23
UROGEN PHARMA, INC.
$21
Antares Pharma, Inc.
$20
Cook Medical LLC
$18
Olympus America Inc.
$17
Verity Pharmaceuticals Inc.
$16
Axonics, Inc.
$16
Top 3 companies account for 38.7% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$509
Antares Pharma, Inc.
$317
PFIZER INC.
$288
Astellas Pharma US Inc
$214
Sumitomo Pharma America, Inc.
$129
Dendreon Pharmaceuticals LLC
$126
PROCEPT BioRobotics Corporation
$122
Innovation Technologies Inc
$95
Ferring Pharmaceuticals Inc.
$76
ABBVIE INC.
$76
BOSTON SCIENTIFIC CORPORATION
$69
C. R. Bard, Inc. & Subsidiaries
$63
Axonics, Inc.
$56
UROGEN PHARMA, INC.
$52
Progenics Pharmaceuticals, Inc.
$46
Supernus Pharmaceuticals, Inc.
$42
Sun Pharmaceutical Industries Inc.
$40
Blue Earth Diagnostics Limited
$39
Caldera Medical, Inc
$37
Olympus America Inc.
$35
Endo Pharmaceuticals Inc.
$34
Pacira Pharmaceuticals Incorporated
$33
Merck Sharp & Dohme Corporation
$32
Allergan Inc.
$32
Janssen Biotech, Inc.
$27
Laborie Medical Technologies Corp.
$27
Tempus AI, Inc
$25
Eisai Inc.
$23
UroGen Pharma, Inc.
$21
Merck Sharp & Dohme LLC
$21
Clovis Oncology, Inc.
$20
AstraZeneca Pharmaceuticals LP
$19
Levita Magnetics International Corp
$19
AbbVie, Inc.
$19
Cook Medical LLC
$18
ACCORD HEALTHCARE, INC.
$18
Retrophin, Inc.
$18
Amgen Inc.
$16
Verity Pharmaceuticals Inc.
$16
Accord Healthcare, Inc.
$15
Coloplast Corp
$15
COLOPLAST CORP
$13
Top 3 companies account for 38.2% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · ADVANCE · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · Desara · ERLEADA · Erleada · Exparel · Flexiva · GENERAL BPH · GENERAL FEMALE SUI · GENERAL ONCOLOGY · GENERAL - KIDNEY STONE DISEASE · IRRISEPT · JELMYTO · KEYTRUDA · LITHOVUE · LYNPARZA · Lenvima · LithoVue · Lupron Depot · MYRBETRIQ · Magnetic Surgery · Moses 550 D\F\L · Myrbetriq · NICORE · NOCDURNA · ORGOVYX · OTREXUP · Olympus Stents · Otrexup · PROVENGE · PYLARIFY · RESONANCE · REZUM · ReTrace · Rezum Generator · Rubraca · SOLYX · SPACEOAR VUE · SpaceOAR VUE System - 10mL · SpeediCath · TLANDO · TOVIAZ · Trelstar · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA · iTIND System · rezum Generator
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an urology physician in Grapevine?
Compare urology physicians in the Grapevine area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians in nearby ZIP areas
180
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
BAYLOR SCOTT & WHITE MEDICAL CENTER GRAPEVINE
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Frey is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Frey experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Frey performed 640 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Frey receive payments from pharmaceutical companies?
Yes. Dr. Frey received a total of $2,917 from 42 companies across 139 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Frey's costs compare to other urology physicians in Grapevine?
Dr. Frey's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Frey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →